Administrative Supplement for DePaul-Silva K22 award
德保罗-席尔瓦 K22 奖行政补充
基本信息
- 批准号:10675275
- 负责人:
- 金额:$ 5.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdministrative SupplementAdultAffectAnimal ModelAnti-Inflammatory AgentsAttentionAutomobile DrivingBiological AssayBiotinylationBloodBrainCellsCentral Nervous System Viral DiseasesCephalicChronicDataDevelopmentDiseaseDown-RegulationEncephalitisEpilepsyFlow CytometryGABA ReceptorGenerationsGeneticGrantHippocampus (Brain)HomeostasisInfectionInfiltrationInflammationInflammatoryInterleukin-10Interleukin-6InterleukinsInterventionK22 AwardKnowledgeLaboratoriesLeadLearningMeasuresMentorsMicroRNAsMicrogliaModelingMotor SeizuresMusMyeloid CellsNeuraxisNeuronsPathogenesisPathologicPathway interactionsPatientsPersonsPharmaceutical PreparationsPharmacologyPhasePhenotypePlayPopulationPositioning AttributeRecombinant ProteinsRecurrenceRefractoryResearchRoleSeizuresSeveritiesSeverity of illnessSignal PathwaySignal TransductionSourceStimulusTMEVTNF geneTechniquesTemporal Lobe EpilepsyTestingTimeTissuesTrainingTransforming Growth FactorsViralViral EncephalitisVirusVirus DiseasesWorkacquired epilepsyacute infectionastrogliosisbrain parenchymacareercytokineexperimental studyimprovedmacrophagemouse modelnervous system disorderneuroinflammationneuron lossnew therapeutic targetnovelnovel therapeuticsperipheral bloodpreventreceptorreceptor expressionresponseskillstherapeutic targettissue repairtraffickingtranscriptome sequencing
项目摘要
Abstract/Project Summary
Temporal lobe epilepsy (TLE) is the most prevalent form of acquired epilepsy. 30% of the patients are
refractory to therapy and new treatments are urgently needed. Viral infection of the central nervous system (CNS)
is a significant cause of TLE, and, while encephalitis is an important contributor, the mechanisms of how
inflammation leads to seizures is unclear. Using the first mouse model of viral-induced TLE, which was developed
by our laboratory, we found that induction of acute seizures is associated with blood peripheral macrophage
infiltration into the brain and secretion of pro-inflammatory cytokines, primarily IL-6.
Through RNA sequencing (RNAseq) of infiltrating macrophages isolated from the brains of TMEV-infected
mice at the peak of seizure activity, I found that a population of CNS-infiltrating macrophages expresses high
levels of the triggering receptor expressed on myeloid cells-1 (TREM1). Activation of TREM1 leads to the
secretion of pro-inflammatory cytokines. Increased TREM1 expression is associated with inflammatory
conditions, and inhibition of TREM1 function ameliorates inflammation and disease severity in several animal
models of inflammatory diseases. However, the involvement of TREM1 in the development of acute seizures is
unknown. In Aim 1 I will determine the time course of TREM1 expression in brain-infiltrating macrophages, and
address whether genetic and pharmacological inhibition of TREM1 decreases the development of acute seizures
in TMEV-infected mice, via videoEEG. The pro-inflammatory cytokine IL-6, which is mainly produced by brain
infiltrating macrophages during TMEV infection, plays a pivotal role in inducing seizures; however how IL-6 does
it is unknown. In Aim 2, I will determine whether IL-6 induces downregulation of neuronal GABA receptors, via
biotinylation assay, and address which IL-6 pathway (classical or trans-signaling) is involved in acute seizures.
Since inflammatory macrophages in the brain are associated with generation of acute seizures in TMEV-infected
mice, in Aim 3 I will determine whether skewing macrophages towards an anti-inflammatory phenotype will affect
the development of acute seizures, via videoEEG. I will also identify microRNAs in brain-infiltrating macrophages
that are driving inflammation during the course of acute seizure generation in TMEV-infected mice. VideoEEG
and receptor biotinylation assay are critical techniques I will learn during my mentored phase (Aim1/Aim2a), that
will be essential to carry out experiments in Phase II (Aim2b/Aim3). These new skills, combined to my previous
training, will put me in a unique position to address crucial questions related to neuroinflammation and epilepsy
in my own laboratory using cutting edge approaches, and will substantially impacting my research and career.
These aims will improve the knowledge of the relationship between inflammation and seizures, and has the
great potential of revealing inflammatory macrophages as a novel therapeutic target of neuroinflammation,
allowing for the development of novel intervention to prevent and treat the development of acquired epilepsy.
摘要/项目摘要
颞叶癫痫(TLE)是获得性癫痫最常见的形式。30%的患者是
治疗难治,迫切需要新的治疗方法。中枢神经系统(CNS)病毒感染
是TLE的一个重要原因,虽然脑炎是一个重要的贡献者,但其机制是
炎症导致癫痫发作的原因尚不清楚。利用第一个病毒诱导的小鼠TLE模型,
我们实验室发现,急性癫痫的诱发与外周血巨噬细胞有关。
渗透到大脑和分泌促炎细胞因子,主要是IL-6。
通过对从TMEV感染的脑组织中分离的浸润性巨噬细胞的RNA测序(RNAseq)
在小鼠癫痫发作活动的高峰期,我发现一群中枢神经系统浸润性巨噬细胞高表达
髓系细胞-1(TREM1)上表达的触发受体的水平。TREM1的激活导致
促炎症细胞因子的分泌。TREM1表达增加与炎症相关
条件和抑制TREM1功能可以改善几种动物的炎症和疾病严重程度
炎症性疾病模型。然而,TREM1参与了急性癫痫的发展。
未知。在目标1中,我将测定TREM1在脑浸润性巨噬细胞中表达的时间进程,以及
TREM1的遗传和药物抑制是否会减少急性癫痫的发生
在感染TMEV的小鼠中,通过视频脑电图。促炎细胞因子IL-6,主要由大脑产生
在TMEV感染中渗透巨噬细胞,在诱发癫痫中起着关键作用;然而,IL-6如何
这是未知的。在目标2中,我将确定IL-6是否通过以下途径诱导神经元GABA受体下调
生物素化分析,以及IL-6途径(经典或反式信号)在急性癫痫发作中的作用。
由于脑部炎性巨噬细胞与TMEV感染的急性癫痫的发生有关
小鼠,在目标3中,我将确定巨噬细胞向抗炎表型倾斜是否会影响
通过视频脑电波观察急性癫痫的发展。我还将在脑内渗透的巨噬细胞中鉴定microRNAs
在TMEV感染的小鼠的急性癫痫发作过程中,它们是推动炎症的因素。视频脑电波
和受体生物素化试验是我在指导阶段(Aim1/Aim2a)学习的关键技术,
将是在第二阶段(Aim2b/Aim3)进行实验所必需的。这些新技能,结合到我以前的
培训,将使我处于一个独特的位置来解决与神经炎症和癫痫相关的关键问题
在我自己的实验室里使用尖端方法,并将对我的研究和职业生涯产生重大影响。
这些目的将提高对炎症和癫痫之间关系的认识,并具有
揭示炎性巨噬细胞作为神经炎症治疗新靶点的巨大潜力
允许开发新的干预措施来预防和治疗获得性癫痫的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ana Beatriz de Paula e Silva其他文献
Ana Beatriz de Paula e Silva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ana Beatriz de Paula e Silva', 18)}}的其他基金
The role of Infiltrating Macrophages in Seizure Generation Following CNS Infection
浸润巨噬细胞在中枢神经系统感染后癫痫发作中的作用
- 批准号:
10284661 - 财政年份:2021
- 资助金额:
$ 5.4万 - 项目类别:
The role of Infiltrating Macrophages in Seizure Generation Following CNS Infection
浸润巨噬细胞在中枢神经系统感染后癫痫发作中的作用
- 批准号:
10463765 - 财政年份:2021
- 资助金额:
$ 5.4万 - 项目类别:
The role of Infiltrating Macrophages in Seizure Generation Following CNS Infection
浸润巨噬细胞在中枢神经系统感染后癫痫发作中的作用
- 批准号:
10732561 - 财政年份:2021
- 资助金额:
$ 5.4万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Research Grant